Your career starts on Magnet.me
Create a profile and receive smart job recommendations based on your liked jobs.
Pleased to meet you, we are Galapagos, a biotechnology company with operations in Europe and the U.S. dedicated to developing transformational medicines for more years of life and quality of life.
We are in the business of changing lives. Focusing on high unmet medical needs, we synergize compelling science, technology, and collaborative approaches to create a deep pipeline of best-in-class small molecules, CAR-T therapies and biologics in oncology and immunology. With capabilities from lab to patient, including a decentralized CAR-T manufacturing network, we are committed to challenging the status quo and delivering results for our patients, employees and shareholders.
Project Scope
We are looking for an enthusiastic and highly motivated Data Management Leader with solid Clinical Data Management (DM) expertise and standards knowledge to take responsibility of oversight activities for Galapagos’ clinical trials, supporting the Clinical Study Team (CST) through managing the collection, review and reporting of clinical data and related activities during the planning, set-up, conduct, and close-out of clinical trials.
Your mission
Data Standards
Who are you?
What's in it for you?
At Galapagos, we are committed to building meaningful partnerships with our consultants, offering a collaborative and supportive environment where you are recognized as an integral part of the team. As a consultant, you will engage in a variety of projects, enabling you to expand your expertise across multiple domains. Our aim is to support your professional growth while fostering a dynamic workplace that values and empowers you as an equal partner.
We’re in the business of changing lives. In our quest to discover, develop and deliver life-improving medicines, we go where no one has ever gone before.
Galapagos is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action. Galapagos’ pipeline comprises Phase 3 through to discovery programs in cystic fibrosis, inflammation, fibrosis, osteoarthritis and other indications.
Change language to: Dutch
This page is optimised for people from the Netherlands. View the version optimised for people from the UK.